Fulgent Genetics DIO Ratio 2011-2026 | FLGT

Annual DIO Ratio Fulgent Genetics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	7.17	10.7	9.86	17.5	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
17.5	7.17	11.3

Quarterly DIO Ratio Fulgent Genetics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
0.71	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.71	0.71	0.71

DIO Ratio of other stocks in the Diagnostics research industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	156	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	25.4	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	137	-	-	$ 1.31 B	USA
Co-Diagnostics CODX	1.69 K	$ 4.5	-10.89 %	$ 5.99 M	USA
Castle Biosciences CSTL	47.2	$ 21.08	4.77 %	$ 611 M	USA
Aspira Women's Health AWH	32.2	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	21.9	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	0.213	$ 151.82	-0.28 %	$ 11.9 B	Irlanda
Illumina ILMN	138	$ 160.03	1.26 %	$ 24.8 B	USA
Oxford Immunotec Global PLC OXFD	210	-	-	$ 562 M	Britain
Guardant Health GH	82.1	$ 130.12	4.19 %	$ 16.3 B	USA
CareDx, Inc CDNA	48.3	$ 22.75	3.64 %	$ 1.21 B	USA
Chembio Diagnostics CEMI	97.6	-	0.22 %	$ 16.8 M	USA
Interpace Biosciences IDXG	29.1	$ 1.74	3.57 %	$ 7.7 M	USA
HTG Molecular Diagnostics HTGM	116	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	89.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	131	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	42.1	-	-	$ 7.1 B	Australia
NeoGenomics NEO	24.4	$ 11.44	4.47 %	$ 1.47 B	USA
Genetron Holdings Limited GTH	62.8	-	0.12 %	$ 80.1 M	China
DermTech DMTK	33.5	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	40.4	$ 99.98	-0.03 %	$ 6.75 B	USA
Charles River Laboratories International CRL	35.3	$ 189.85	1.83 %	$ 9.41 B	USA
Pacific Biosciences of California PACB	173	$ 1.37	-0.72 %	$ 411 M	USA
Exact Sciences Corporation EXAS	60.9	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	79	$ 1 162.79	2.1 %	$ 24 B	Schweiz
Myriad Genetics MYGN	42.8	$ 4.54	3.42 %	$ 420 M	USA
Natera NTRA	25.8	$ 222.82	4.38 %	$ 30.5 B	USA
Personalis PSNL	12.1	$ 9.75	-2.89 %	$ 870 M	USA
Koninklijke Philips N.V. PHG	89	$ 26.5	2.63 %	$ 25.1 B	Niderland
Senseonics Holdings SENS	104	$ 7.43	4.21 %	$ 310 M	USA
QIAGEN N.V. QGEN	141	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	1.02 K	-	-	$ 2.69 B	USA
Biomerica BMRA	147	$ 2.05	-0.92 %	$ 4.71 M	USA
Laboratory Corporation of America Holdings LH	18.9	$ 271.24	3.52 %	$ 22.6 B	USA
Twist Bioscience Corporation TWST	51.5	$ 70.06	0.03 %	$ 4.19 B	USA
Thermo Fisher Scientific TMO	86.5	$ 494.07	5.23 %	$ 186 B	USA
Trinity Biotech plc TRIB	212	$ 0.66	-2.32 %	$ 237 M	Irlanda
Motus GI Holdings MOTS	3.37 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	147	$ 9.29	2.43 %	$ 2.01 B	USA
Waters Corporation WAT	528	$ 371.15	2.15 %	$ 22.1 B	USA
Quest Diagnostics Incorporated DGX	9.34	$ 204.53	3.71 %	$ 22.7 B	USA